Copyright  © 2019 Henan Lejia Electronic Technology Co., Ltd.       豫ICP备14004688号    豫郑食药监械经营备20181527号




2017 China medical device industry trend analysis

2017 China medical device industry trend analysis

Company news
Release time:

  2017 China medical device industry trend analysis

  In the past six years, China's medical technology and medical device industry has grown rapidly. It is estimated that the market size of China's medical technology and medical device industry will reach 600 billion yuan in 2019. In the face of such a big dividend, it is especially important to grasp the mainstream direction. Is it to follow the trend of dividends or to fall behind?

  From 2011 to 2016, the average annual compound growth rate of China's medical technology and medical device industry is as high as 20.7%. In 2016, China's medical technology and medical device market was about 370 billion yuan, an increase of 62 billion yuan over 2015. It is about 20.1%. Among them, imaging equipment, in vitro diagnostics and high-value consumables occupy the top three segments of the medical technology and medical device market, accounting for 19%, 16% and 13% of the total market size, respectively.

  However, from the perspective of the ratio of medical equipment, the scale of China's medical equipment market and pharmaceutical market is 1:7, far lower than the global 1:3. From the per capita medical technology and medical equipment costs, China's current per capita cost is only 6 US dollars, while the per capita cost of developed countries is more than 100 US dollars, the United States reached 329 US dollars / person, Switzerland is even reached 513 US dollars / person.

  Therefore, no matter from the method of diagnosis and treatment, or from the level of consumption, China's medical environment is far lower than other countries, but China has a large population, China's medical technology and medical equipment market is absolutely considerable, so much room for growth, for us The dealers have brought considerable benefits.

  Medical technology and medical device market

  In recent years, with the development of China, the state's investment in medical technology and medical device industry has become more and more vigorous, and ordinary people have feelings, not to mention the dealers in the industry.

  Whether it is the optimization of medical equipment approval procedures, centralized procurement of medical supplies and online transactions, or two-vote system and the support of domestic medical equipment, it is unprecedented!

  Of course, in addition to national policies, China's population is gradually aging, the number of per capita visits and medical expenses are increasing, and it is also driving the rapid growth of China's medical technology and medical device industry.

  In 2017, six major trends lead the industry trend

  1. Two-vote system is fully implemented to promote channel transformation

  The hot topic in 2016 is the two-vote system. The major dealers have taken all kinds of unbelievable and questioning attitudes, and now they have been fully guarded. After all, the documents of Fujian and Zhejiang have been released. The channel will be sunk, and small and medium-sized agents will be eliminated, merged, and transformed. Under this trend, there will be three major trends in the industry: horizontal acquisition, vertical extension and transformation.

  Transformation: refers to the transformation of the business model between medical device production enterprises and channel companies. For example, some equipment dealers have transformed CSO in the context of two-vote system, business reform and major rectification; some equipment-agent businesses are in the above context. Or will transform the distribution business.

  In short, the channel mergers, acquisitions, extensions, and transformations will gradually channel the channel links. This is the future way of channel integration under the two-ticket system trend.

  2. Graded diagnosis and treatment bring opportunities for domestic equipment

  Since last year, China’s support for domestic medical equipment has gradually increased. For example, the special approval system for domestically-made excellent innovative medical equipment and preferential efforts, some provinces have set the number of domestic medical equipment purchases, especially at present, China’s primary medical care is Rapid development, so graded diagnosis and treatment can not only bring opportunities for the development of domestically produced equipment, but also play a large role in China's primary medical environment, and improve the primary medical environment. This will not only break the long-term monopoly of China's high-end medical equipment market by foreign companies, but also promote the development of China's primary medical environment.

  Therefore, we will focus on the field of basic equipment such as inspection and diagnosis equipment (especially POCT and rapid inspection equipment), chronic disease related household equipment, medical rehabilitation equipment, doctor follow-up equipment, ultrasound and other safe and simple imaging equipment.

  3. Device-based third-party services

  Where there is interest, there is a market. With the continuous deepening of medical reform and the continuous exploration of various emerging models, the “mutually beneficial model” for hospital service and hospital win-win will be better than the hospital’s life and the hospital’s business. The subversive model is more in line with the current medical business environment. Under this, various types of device-based third-party service organizations will have a lot to offer, and various "Internet +" thinking and models will be integrated into these services.

  From the Health and Welfare Committee's support for third-party diagnosis, imaging and pathology, it can be seen that the emerging intensive service model based on third-party diagnosis, imaging, pathology, logistics, disinfection, maintenance, equipment packaging, etc. of medical devices and equipment will Strongly promote the development of the medical industry. Since these areas are also capital-intensive, it is believed that there will be a large number of investment and mergers and acquisitions.

  4. New technology penetration equipment field

  Early screening technology, artificial intelligence, 3D printing, medical robots, etc. will bring a revolutionary revolution in diagnosis and treatment.

  As the saying goes not to develop in innovation, it will die in the old age! The medical environment in China is indeed starting in other developed countries, but we are standing on the shoulders of giants! While constantly improving our environment, we also follow the times. Different developments, so these new medical technologies and medical devices will be born in the blue-sea market.

  5. Precision medicine gradually evolves from concept to maturity

  From January 2015, the then President of the United States, Mr. Obama proposed the "precise medical plan", the word "precise medical" has become a hot word in the medical field, with the continuous maturity of NGS, gene editing, DNA capture and other technologies. Precision medicine has gradually evolved from concept to maturity. From the perspective of the diagnosis and treatment process, precision medicine can be divided into early screening, disease diagnosis, and prognosis.

  At present, the domestic competition between NGS and ctDNA is booming, and many companies are in a state of turmoil. After the last two years of staking, the industry is about to usher in a reshuffle and more brutal competition. On the enterprise side, the leading companies such as Gene and Gene, Burning Stone Medicine continue to receive capital attention, and emerging forces represented by Yuanma, Gene, Gene Plus, and Technology are catching up at different entry points. .

  6. Overseas investment and M&A momentum continues to be strong

  Since the end of 2016, investment institutions and large enterprises in the market have focused on the investment in medical devices, focusing on sales profits, stable investment opportunities with mature channels, and actively seeking overseas technology companies. Investment to achieve product introduction and complement the domestic channel advantages.

Key words: